(MedPage Today) — Treatment with the supplement berberine failed to reduce visceral adipose tissue or liver fat in adults with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), a randomized trial from China found….
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
